We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cocrystal Pharma Inc | NASDAQ:COCP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.045 | 2.98% | 1.555 | 1.35 | 1.62 | 1.581 | 1.50 | 1.52 | 29,491 | 22:16:11 |
Cocrystal Pharma, Inc.
|
||
(Name of Issuer) |
Common Stock, par value $0.001 per share
|
||
(Title of Class of Securities) |
19188J300 | ||
(CUSIP Number) |
Camielle Green
Associate General Counsel, Secretary OPKO Health, Inc. 4400 Biscayne Boulevard Miami, Florida 33137 Telephone: (305) 575-4100 Phillip Frost, M.D. Frost Gamma Investments Trust Steven D. Rubin 4400 Biscayne Boulevard Miami, Florida 33137 (305) 575-6015 |
||
(Name, address and telephone number of person authorized to receive notices and communications) |
November 13, 2020
|
||
(Date of event which requires filing of this statement) |
* | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
CUSIP No. 19188J300 | Schedule 13D |
PAGE 2 of 8
|
1 |
NAME OF REPORTING PERSONS
OPKO Health, Inc.
|
||||||||||||||||||||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨ (b) ¨
|
||||||||||||||||||||||
3 |
SEC USE ONLY
|
||||||||||||||||||||||
4 |
SOURCE OF FUNDS
WC
|
||||||||||||||||||||||
5 |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
¨
|
||||||||||||||||||||||
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||||||||||||||||||||||
NUMBER OF SHARES
BENEFICIALLY OWNED BY
EACH REPORTING
PERSON
WITH |
7 |
SOLE VOTING POWER
|
|||||||||||||||||||||
2,659,685 |
(1)
|
||||||||||||||||||||||
8 |
SHARED VOTING POWER
|
||||||||||||||||||||||
0 | |||||||||||||||||||||||
9 |
SOLE DISPOSITIVE POWER
|
||||||||||||||||||||||
2,659,685 |
(1)
|
||||||||||||||||||||||
10 |
SHARED DISPOSITIVE POWER
|
||||||||||||||||||||||
0 | |||||||||||||||||||||||
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
||||||||||||||||||||||
|
2,659,685 |
(1)
|
|||||||||||||||||||||
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
|
||||||||||||||||||||||
13 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
||||||||||||||||||||||
3.9 | % |
(2)
|
|||||||||||||||||||||
14 |
TYPE OF REPORTING PERSON
CO
|
CUSIP No. 19188J300 | Schedule 13D |
PAGE 3 of 8
|
1 |
NAME OF REPORTING PERSONS
Phillip Frost, M.D.
|
||||||||||||||||||||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨ (b) ¨
|
||||||||||||||||||||||
3 |
SEC USE ONLY
|
||||||||||||||||||||||
4 |
SOURCE OF FUNDS
OO
|
||||||||||||||||||||||
5 |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
¨
|
||||||||||||||||||||||
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
|
||||||||||||||||||||||
NUMBER OF SHARES
BENEFICIALLY OWNED BY
EACH REPORTING
PERSON
WITH |
7 |
SOLE VOTING POWER
|
|||||||||||||||||||||
3,695,056 |
(1)
|
||||||||||||||||||||||
8 |
SHARED VOTING POWER
|
||||||||||||||||||||||
0 | |||||||||||||||||||||||
9 |
SOLE DISPOSITIVE POWER
|
||||||||||||||||||||||
3,695,056 |
(1)
|
||||||||||||||||||||||
10 |
SHARED DISPOSITIVE POWER
|
||||||||||||||||||||||
0 | |||||||||||||||||||||||
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
||||||||||||||||||||||
|
3,695,056 |
(1)
|
|||||||||||||||||||||
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
|
||||||||||||||||||||||
13 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
||||||||||||||||||||||
5.4 | % |
(2)
|
|||||||||||||||||||||
14 |
TYPE OF REPORTING PERSON
IN
|
CUSIP No. 19188J300 | Schedule 13D |
PAGE 4 of 8
|
1 |
NAME OF REPORTING PERSONS
Frost Gamma Investments Trust
|
||||||||||||||||||||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨ (b) ¨
|
||||||||||||||||||||||
3 |
SEC USE ONLY
|
||||||||||||||||||||||
4 |
SOURCE OF FUNDS
OO
|
||||||||||||||||||||||
5 |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
¨
|
||||||||||||||||||||||
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Florida
|
||||||||||||||||||||||
NUMBER OF SHARES
BENEFICIALLY OWNED BY
EACH REPORTING
PERSON
WITH |
7 |
SOLE VOTING POWER
|
|||||||||||||||||||||
3,655,265 | |||||||||||||||||||||||
8 |
SHARED VOTING POWER
|
||||||||||||||||||||||
0 | |||||||||||||||||||||||
9 |
SOLE DISPOSITIVE POWER
|
||||||||||||||||||||||
3,655,265 | |||||||||||||||||||||||
10 |
SHARED DISPOSITIVE POWER
|
||||||||||||||||||||||
0 | |||||||||||||||||||||||
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
||||||||||||||||||||||
|
3,655,265 | ||||||||||||||||||||||
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
|
||||||||||||||||||||||
13 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
||||||||||||||||||||||
5.3 | % |
(1)
|
|||||||||||||||||||||
14 |
TYPE OF REPORTING PERSON
OO
|
CUSIP No. 19188J300 | Schedule 13D |
PAGE 5 of 8
|
1 |
NAME OF REPORTING PERSONS
Steven D. Rubin
|
||||||||||||||||||||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨ (b) ¨
|
||||||||||||||||||||||
3 |
SEC USE ONLY
|
||||||||||||||||||||||
4 |
SOURCE OF FUNDS
OO
|
||||||||||||||||||||||
5 |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
¨
|
||||||||||||||||||||||
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
|
||||||||||||||||||||||
NUMBER OF SHARES
BENEFICIALLY OWNED BY
EACH REPORTING
PERSON
WITH |
7 |
SOLE VOTING POWER
|
|||||||||||||||||||||
64,239 |
(1)
|
||||||||||||||||||||||
8 |
SHARED VOTING POWER
|
||||||||||||||||||||||
0 | |||||||||||||||||||||||
9 |
SOLE DISPOSITIVE POWER
|
||||||||||||||||||||||
64,239 |
(1)
|
||||||||||||||||||||||
10 |
SHARED DISPOSITIVE POWER
|
||||||||||||||||||||||
0 | |||||||||||||||||||||||
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
||||||||||||||||||||||
|
64,239 |
(1)
|
|||||||||||||||||||||
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
|
||||||||||||||||||||||
13 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
||||||||||||||||||||||
0.1 | % |
(2)
|
|||||||||||||||||||||
14 |
TYPE OF REPORTING PERSON
IN
|
CUSIP No. 19188J300 | Schedule 13D |
PAGE 6 of 8
|
ITEM 4.
|
Purpose of Transaction.
|
ITEM 5.
|
Interest in Securities of the Issuer.
|
CUSIP No. 19188J300 | Schedule 13D |
PAGE 7 of 8
|
Name |
Number of Shares of Common Stock
Beneficially Owned |
Sole or Shared
Voting Power |
Sole or Shared
Dispositive Power |
Percentage of Class | ||||||||||||||||||||||||||||
Jane H. Hsiao, Ph.D., MBA | 297,730 |
(1)
|
Sole | Sole | 0.4 | % |
(2)
|
|||||||||||||||||||||||||
Richard A. Lerner, M.D. | 3,623 |
Shared(3)
|
Shared(3)
|
0.01 | % |
(2)
|
CUSIP No. 19188J300 | Schedule 13D |
PAGE 8 of 8
|
OPKO Health, Inc. | |||||||||||||||||||||||
Dated: | November 19, 2020 | By: |
/s/ Camielle Green
|
||||||||||||||||||||
Name: | Camielle Green | ||||||||||||||||||||||
Title: | Associate General Counsel, Secretary | ||||||||||||||||||||||
Phillip Frost, M.D. | |||||||||||||||||||||||
Dated: | November 19, 2020 | By: |
/s/ Phillip Frost, M.D.
|
||||||||||||||||||||
Name: | Phillip Frost, M.D. | ||||||||||||||||||||||
Frost Gamma Investments Trust | |||||||||||||||||||||||
Dated: | November 19, 2020 | By: |
/s/ Phillip Frost, M.D.
|
||||||||||||||||||||
Name: | Phillip Frost, M.D. | ||||||||||||||||||||||
Title: | Trustee | ||||||||||||||||||||||
Steven D. Rubin | |||||||||||||||||||||||
Dated: | November 19, 2020 | By: |
/s/ Steven D. Rubin
|
||||||||||||||||||||
Name: | Steven D. Rubin | ||||||||||||||||||||||
1 Year Cocrystal Pharma Chart |
1 Month Cocrystal Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions